SCA
OPK icon

Sassicaia Capital Advisers’s Opko Health OPK Stock Holding History

Sassicaia Capital Advisers’s Portfolio OPK Stock Details OPK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,000
Closed -$19.2K – 33
2024
Q1 		$19.2K Buy
+16,000
New +$16K 0.08% 23

Other funds holding OPK

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Sassicaia Capital Advisers's OPK Position: Q2 2024 in Review

Sassicaia Capital Advisers sold out of Opko Health (OPK) in Q2 2024, closing a stake of 16,000 shares — an estimated $19.2K sold.

Sassicaia Capital Advisers first reported a position in OPK in Q1 2024 and held it in 1 quarter. The position peaked at $19.2K in Q1 2024. 232 funds tracked by Wall St. Rank hold OPK as of Q2 2024.

  • Sassicaia Capital Advisers reported no remaining Opko Health position as of Q2 2024 after selling out during the quarter.
  • Sassicaia Capital Advisers sold 16,000 Opko Health shares in Q2 2024, an estimated $19.2K.
  • Sassicaia Capital Advisers first reported a position in Opko Health in Q1 2024 and held it in 1 quarter.
  • Sassicaia Capital Advisers's Opko Health position peaked at $19.2K in Q1 2024.
  • 232 funds tracked by Wall St. Rank held Opko Health as of Q2 2024.

Based on Sassicaia Capital Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.